SCHEMBL4883200

SCHEMBL4883200

O=C(NCc1ccc(Cl)c(Cl)c1)c1cn[nH]c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.62
LMNA P02545 1/20 0.57
TSHR P16473 2/20 0.56
EPHX2 P34913 1/20 0.55
HDAC4 P56524 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53
MEN1 O00255 1/20 0.52
ALDH1A1 P00352 1/20 0.52
KMT2A Q03164 1/20 0.52
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.51
ROCK2 O75116 4/20 0.51
ROCK1 Q13464 3/20 0.51
WDR5 P61964 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23586414 0.82 ROCK2 (0.66) HDAC1HDAC6ROCK2ROCK1NAMPT
SCHEMBL8108036 0.81 EPHX2 (0.79) MAOBLMNATSHREPHX2HDAC4
SCHEMBL4564344 0.80 MAOB (0.58) MAOBLMNATSHREPHX2HDAC4
SCHEMBL18741074 0.78 L3MBTL1 (0.61) LMNAEPHX2MEN1KMT2ASMN1; SMN2
SCHEMBL4879445 0.78 ROCK2 (0.60) LMNAHDAC8HDAC6HPGDSMN1; SMN2
SCHEMBL3461067 0.78 EPHX2 (0.66) MAOBLMNATSHREPHX2HDAC4
SCHEMBL360181 0.78 ROCK2 (0.65) ROCK2ROCK1
SCHEMBL18741190 0.77 LMNA (0.56) LMNAHPGDSMN1; SMN2ROCK2ROCK1
SCHEMBL18741188 0.77 ROCK2 (0.61) ALDH1A1HPGDROCK2ROCK1
SCHEMBL9120814 0.77 HDAC4 (0.67) MAOBLMNATSHREPHX2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES ICAGEN, INC. (US) 2008-03-13 US disclosed
US-7223782-B2 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2007-05-29 US disclosed
US-20050049237-A1 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2005-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES SCN3A, TRPV3, HCN3 MAOB 3644/4885LMNA 3896/4885TSHR 3666/4885
US-20050049237-A1 Pyrazole-amides and -sulfonamides SCN3A, TRPV3, HCN3 MAOB 3644/4885LMNA 3896/4885TSHR 3666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.